Interstitial Fluid Pressure Estimation in Breast Cancer Using 3D Subharmonic Signals From Contrast-Enhanced Ultrasound

Who is this study for? Patients with breast cancer
What treatments are being studied? Ultrasonsgraphy+Perflutren Lipid Microcpheres+Contrast - Enhanced Ultrasound
Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

This clinical trial studies the use of contrast-enhanced ultrasound (CEUS) in estimating tissue pressure in patients with breast cancer. Diagnostic procedures, such as CEUS, may help estimate tissue pressure noninvasively.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 21
Healthy Volunteers: f
View:

• Provide signed and dated informed consent form

• Be conscious, willing and able to comply with all study procedures and be available for the duration of the study

• At least 21 years old

• Be scheduled for a breast biopsy (Breast Imaging Reporting and Data System \[BIRAD\] 4, 4A, 4B, 4C or 5)

• Patient with an at least 1 cm mass located at \< 3 cm depth, approachable by 2.5 inch needle

• Be medically stable as determined by the investigator

• If a female of child-bearing potential, must have a negative urine pregnancy test within 24 hours prior to administration of Definity

Locations
United States
Pennsylvania
Thomas Jefferson University Hospital
RECRUITING
Philadelphia
Contact Information
Primary
Kibo Nam, MD
Kibo.Nam@jefferson.edu
215-955-6261
Time Frame
Start Date: 2020-11-24
Estimated Completion Date: 2025-01-01
Participants
Target number of participants: 25
Treatments
Experimental: Diagnostic (CEUS)
Patients undergo ultrasound without contrast. Patients then receive Definity IV over 15 minutes and undergo CEUS.
Related Therapeutic Areas
Sponsors
Leads: Thomas Jefferson University

This content was sourced from clinicaltrials.gov